世界の勃起不全薬市場レポート2020年

QYResearchが発行した調査報告書(QYR21FB5010)
◆英語タイトル:Global Erectile Dysfunction Drugs Sales Market Report 2020
◆商品コード:QYR21FB5010
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:135
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の勃起不全薬市場について種類別(シルデナフィル、タダラフィル、その他)、用途別(病院薬局、民間クリニック、小売薬局、Eコマース(B2B)、Eコマース(B2C))、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・勃起不全薬市場の概要
・世界の主要地域別勃起不全薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の勃起不全薬市場規模2015-2026:種類別(シルデナフィル、タダラフィル、その他)
・世界の勃起不全薬市場規模2015-2026:用途別(病院薬局、民間クリニック、小売薬局、Eコマース(B2B)、Eコマース(B2C))
・勃起不全薬のアメリカ市場規模2015-2020
・勃起不全薬のヨーロッパ市場規模2015-2020
・勃起不全薬の中国市場規模2015-2020
・勃起不全薬の日本市場規模2015-2020
・勃起不全薬の東南アジア市場規模2015-2020
・勃起不全薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・勃起不全薬の製造コスト分析
・販売チャネル、流通業者、顧客
・勃起不全薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.

Market Analysis and Insights: Global Erectile Dysfunction Drugs Market
The global Erectile Dysfunction Drugs market size is projected to reach US$ 8119.6 million by 2026, from US$ 5724 million in 2020, at a CAGR of 6.0% during 2021-2026.

Global Erectile Dysfunction Drugs Scope and Market Size
The global Erectile Dysfunction Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Erectile Dysfunction Drugs market is segmented into
Sildenafil
Tadalafil
Others
In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.

Segment by Application, the Erectile Dysfunction Drugs market is segmented into
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.

The Erectile Dysfunction Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Erectile Dysfunction Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Erectile Dysfunction Drugs Market Share Analysis
Erectile Dysfunction Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Erectile Dysfunction Drugs business, the date to enter into the Erectile Dysfunction Drugs market, Erectile Dysfunction Drugs product introduction, recent developments, etc.

The major vendors covered:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.

【レポートの目次】

1 Erectile Dysfunction Drugs Market Overview
1.1 Erectile Dysfunction Drugs Product Scope
1.2 Erectile Dysfunction Drugs Segment by Type
1.2.1 Global Erectile Dysfunction Drugs Sales by Type (2020-2026)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Drugs Segment by Application
1.3.1 Global Erectile Dysfunction Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Erectile Dysfunction Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Erectile Dysfunction Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Erectile Dysfunction Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Erectile Dysfunction Drugs Price Trends (2015-2026)

2 Erectile Dysfunction Drugs Estimate and Forecast by Region
2.1 Global Erectile Dysfunction Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Erectile Dysfunction Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Erectile Dysfunction Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Erectile Dysfunction Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.3 China Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.6 India Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
3 Global Erectile Dysfunction Drugs Competition Landscape by Players
3.1 Global Top Erectile Dysfunction Drugs Players by Sales (2015-2020)
3.2 Global Top Erectile Dysfunction Drugs Players by Revenue (2015-2020)
3.3 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Drugs as of 2019)
3.4 Global Erectile Dysfunction Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Erectile Dysfunction Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Erectile Dysfunction Drugs Players (Opinion Leaders)
4 Global Erectile Dysfunction Drugs Market Size by Type
4.1 Global Erectile Dysfunction Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Erectile Dysfunction Drugs Price by Type (2015-2020)
4.2 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Erectile Dysfunction Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Erectile Dysfunction Drugs Price Forecast by Type (2021-2026)
5 Global Erectile Dysfunction Drugs Market Size by Application
5.1 Global Erectile Dysfunction Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Erectile Dysfunction Drugs Price by Application (2015-2020)
5.2 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Erectile Dysfunction Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Erectile Dysfunction Drugs Price Forecast by Application (2021-2026)

6 United States Erectile Dysfunction Drugs Market Facts & Figures
6.1 United States Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
6.2 United States Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
6.3 United States Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)

7 Europe Erectile Dysfunction Drugs Market Facts & Figures
7.1 Europe Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)

8 China Erectile Dysfunction Drugs Market Facts & Figures
8.1 China Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
8.2 China Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
8.3 China Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)

9 Japan Erectile Dysfunction Drugs Market Facts & Figures
9.1 Japan Erectile Dysfunction Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)

10 Southeast Asia Erectile Dysfunction Drugs Market Facts & Figures
10.1 Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)

11 India Erectile Dysfunction Drugs Market Facts & Figures
11.1 India Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
11.2 India Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
11.3 India Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Erectile Dysfunction Drugs Business
12.1 Eli Lilly
12.1.1 Eli Lilly Corporation Information
12.1.2 Eli Lilly Business Overview
12.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly Erectile Dysfunction Drugs Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Erectile Dysfunction Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Erectile Dysfunction Drugs Products Offered
12.3.5 Bayer Recent Development
12.4 BaiYunShan General Factory
12.4.1 BaiYunShan General Factory Corporation Information
12.4.2 BaiYunShan General Factory Business Overview
12.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Products Offered
12.4.5 BaiYunShan General Factory Recent Development
12.5 S.K. Chemicals
12.5.1 S.K. Chemicals Corporation Information
12.5.2 S.K. Chemicals Business Overview
12.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 S.K. Chemicals Erectile Dysfunction Drugs Products Offered
12.5.5 S.K. Chemicals Recent Development
12.6 Teva Pharma
12.6.1 Teva Pharma Corporation Information
12.6.2 Teva Pharma Business Overview
12.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharma Erectile Dysfunction Drugs Products Offered
12.6.5 Teva Pharma Recent Development
12.7 Dong-A ST
12.7.1 Dong-A ST Corporation Information
12.7.2 Dong-A ST Business Overview
12.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dong-A ST Erectile Dysfunction Drugs Products Offered
12.7.5 Dong-A ST Recent Development
12.8 Metuchen Pharma
12.8.1 Metuchen Pharma Corporation Information
12.8.2 Metuchen Pharma Business Overview
12.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Metuchen Pharma Erectile Dysfunction Drugs Products Offered
12.8.5 Metuchen Pharma Recent Development
12.9 Seoul Pharma
12.9.1 Seoul Pharma Corporation Information
12.9.2 Seoul Pharma Business Overview
12.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Seoul Pharma Erectile Dysfunction Drugs Products Offered
12.9.5 Seoul Pharma Recent Development
12.10 CSBIO.
12.10.1 CSBIO. Corporation Information
12.10.2 CSBIO. Business Overview
12.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSBIO. Erectile Dysfunction Drugs Products Offered
12.10.5 CSBIO. Recent Development

13 Erectile Dysfunction Drugs Manufacturing Cost Analysis
13.1 Erectile Dysfunction Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Erectile Dysfunction Drugs
13.4 Erectile Dysfunction Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Erectile Dysfunction Drugs Distributors List
14.3 Erectile Dysfunction Drugs Customers

15 Market Dynamics
15.1 Erectile Dysfunction Drugs Market Trends
15.2 Erectile Dysfunction Drugs Opportunities and Drivers
15.3 Erectile Dysfunction Drugs Market Challenges
15.4 Erectile Dysfunction Drugs Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【掲載企業】

Eli Lilly、Pfizer、Bayer、BaiYunShan General Factory、S.K. Chemicals、Teva Pharma、Dong-A ST、Metuchen Pharma、Seoul Pharma、CSBIO.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の勃起不全薬市場レポート2020年(Global Erectile Dysfunction Drugs Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。